Regeneron has been treading water for the past six months, recording a small return of 3.4% while holding steady at $717.22. The stock also fell short of the S&P 500’s 9.9% gain during that period.

At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage rates that help you manage your financial life.

Tarrytown, New York-based Regeneron Pharmaceuticals, Inc. (REGN) is a leading biotechnology company focused on discovering, ...

Check out the latest Regeneron Pharmaceuticals Inc. (REGN) stock quote and chart. View real-time stock prices & the company’s financial overview to help with your trading & investment.

Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) is one of the best medical stocks to invest in according to billionaires.

Looking ahead to 2030, our model projects REGN could trade at an average price of $1,253.87, with a potential range between $940.40 and $1,567.34. This represents a potential 104.0% return from ...

Regeneron (REGN) could be a solid choice for investors given its recent upgrade to a Zacks Rank #1 (Strong Buy). This upgrade is essentially a reflection of an upward trend in earnings estimates -- ...

As of Monday, May 18, Regeneron Pharmaceuticals, Inc.’s REGN share price has dipped by 10.63%, which has investors ...

Investors in Regeneron Pharmaceuticals, Inc. (Symbol: REGN) saw new options become available today, for the November 7th expiration. At Stock Options Channel, our YieldBoost formula has looked up and ...

After a five-year 930% gain, it is possible that shares of Regeneron Pharmaceuticals (REGN) have run their course. For the second time in three months, the stock has fallen below $240 after exceeding ...